(Reuters) - The U.S. Food and Drug Administration on Tuesday rejected Prevention Bio Inc.'s approval of the experimental diabetes drug teplizumab, citing insufficient data,...
Tampa, FL, May 20, 2021 (GLOBE NEWSWIRE) - via NewMediaWire - B2Digital Incorporated (the "Company" or "B2Digital") (OTCMKTS: BTDG), the premier mixed martial arts...